Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus

Hematopoietic Stem Cell Transplantation for Autoimmune Disease

(2020) Tobias Alexander et al.   Annual Review of Medicine

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

(2018) Keith M. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

(2017) Paolo A. Muraro et al.   JAMA Neurology

Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease

(2016) Frances T. Hakim et al.   JOURNAL OF IMMUNOLOGY

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

(2016) Harold L Atkins et al.   LANCET

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

(2016) Jing He et al.   NATURE MEDICINE

Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

(2014) Mohamed L. Sorror et al.   JOURNAL OF CLINICAL ONCOLOGY

Host Lymphocyte Depletion as a Strategy to Facilitate Early Full Donor Chimerism after Reduced-Intensity Allogeneic Stem Cell Transplantation

(2013) Rachel B. Salit et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice

(2013) Olivia Weigert et al.   ARTHRITIS RESEARCH & THERAPY

Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies

(2012) Rachel B. Salit et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity

(2012) H Hanaoka et al.   LUPUS

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

(2012) B Alchi et al.   LUPUS

Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus

(2011) G. G. Illei et al.   ANNALS OF THE RHEUMATIC DISEASES

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

(2011) B. W. Higgs et al.   ANNALS OF THE RHEUMATIC DISEASES

Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2011) N. M. Hardy et al.   CLINICAL CANCER RESEARCH

Regulatory T cells and Foxp3

(2011) Alexander Y. Rudensky   IMMUNOLOGICAL REVIEWS

Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients

(2011) Brandon W. HIGGS et al.   International Journal of Rheumatic Diseases

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

(2011) C. Uhlenhaut et al.   Transplant Infectious Disease

Biologics in the treatment of systemic lupus erythematosus

(2010) Aisha Lateef et al.   CURRENT OPINION IN RHEUMATOLOGY

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

(2008) T. Alexander et al.   BLOOD